Clinical Trial

Real-World Data Collection of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis When Used in Covered Endovascular Reconstruction of the Aortic Bifurcation (CERAB) to Treat Aortoiliac Occlusive Disease

Recruiting
View on ClinicalTrials.gov →
Summary
The study will assess the safety and effectiveness of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis ("VBX Device" or also referred to as "VBX Stent Graft") in a post approval setting and evaluate the quality of the use in covered endovascular reconstruction of the aortic bifurcation (CERAB) to treat Aortoiliac Occlusive Disease (AIOD).
Protocol Amendment History 1 change
notable Trial sites expanded: 19 -> 25 locations 2026-05-30
Trial Details
NCT Number NCT06872905
Lead Sponsor W.L.Gore & Associates
Conditions Aortoiliac Occlusive Disease
Enrollment 158 participants
Start Date 2025-05-30
Primary Completion 2027-08-16 (estimated)
Study Completion 2027-08-16 (estimated)
Updated on ClinicalTrials.gov 2026-07-07